Mirvetuximab soravtansine was the first ADC to show efficacy as a therapy for platinum-resistant ovarian cancer. Despite high expectations from early-phase studies, the drug initially did not meet the ...

Discover how advances from various biotechs are bridging treatment gaps in menopause care, offering hope for managing ...

The first, called nirmatrelvir, blocks the activity of an enzyme the COVID-19 virus needs to copy itself, also called repl ...

Researchers have now found a substance that effectively combats glioblastomas, at least in the laboratory: an antidepressant ...